Soliris treats two rare diseases where the body's immune system attacks and destroys red blood cells. (Kelly Crowe/CBC)Canada's drug price watchdog has ordered Alexion Pharmaceuticals to lower the price of Soliris, one of the world's most expensive drugs. In a decision released Wednesday, the Patented Medicine Prices Review Board ruled that the price of Soliris (eculizumab) is excessive. The drug treats two rare diseases where the body's immune system attacks and destroys red blood cells. In Canada, Soliris can cost about $700,000 per patient per year, depending on the weight of the patient.

Source: CBC News September 27, 2017 21:11 UTC